The identification of irreversible rituximab-resistant lymphoma caused by CD20 gene mutations

C-terminal mutations of CD20 constitute part of the mechanisms that resist rituximab therapy. Most CD20 having a C-terminal mutation was not recognized by L26 antibody. As the exact epitope of L26 has not been determined, expression and localization of mutated CD20 have not been completely elucidate...

Descripción completa

Detalles Bibliográficos
Autores principales: Mishima, Y, Terui, Y, Takeuchi, K, Matsumoto-Mishima, Y, Matsusaka, S, Utsubo-Kuniyoshi, R, Hatake, K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255244/
https://www.ncbi.nlm.nih.gov/pubmed/22829136
http://dx.doi.org/10.1038/bcj.2011.11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255244/
https://www.ncbi.nlm.nih.gov/pubmed/22829136
http://dx.doi.org/10.1038/bcj.2011.11

Ejemplares similares